Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
AngioDynamics is a US-based medical technology company that develops and distributes innovative, minimally invasive medical devices. The company focuses on therapeutic solutions in oncology, vascular access, and peripheral vascular diseases, aiming to improve patient care through advanced tumor ablation and thrombectomy technologies.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
AngioDynamics is scheduled to report its next quarterly earnings on 10/01/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
AngioDynamics last reported quarterly earnings on 7/14/2026 (Q2 2026). Earnings per share (EPS) came in at -0.07 USD.
Across its last 5 earnings reports, AngioDynamics stock moved by ±14.5% on average the following day. The largest reaction was +37.7% on 01/08/2025; 3 of 5 reactions were positive.
AngioDynamics has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.